AKT1 and lung cancer: More importantly, it is well known that some signaling pathways such as PI3K/Akt pathway, could cause drug resistance in cancer and a recent study illustrated that the activation of PI3K/Akt pathway by E6 oncogene led to the resistance to cisplatin in HPV-associated lung cancer [22].